| CL2880 |
|
94055-76-2 |
甲磺司特
Suplatast Tosylate (Synonyms: IPD-1151T; Suplatast Tosilate)
-
98+%
|
需詢價(jià) |
C23H33NO7S2 |
|
|
|
| HL1298 |
|
55290-63-6 |
蒼術(shù)素
Atractylodin
-
98+%
|
需詢價(jià) |
C13H10O |
|
|
|
| CLA1350 |
|
1418205-77-2 |
比美吉珠單抗
Bimekizumab
3-5days
95+%
|
￥4500.00 |
— |
|
|
|
| CLA1344 |
|
1357158-22-5 |
夫來(lái)庫(kù)單抗
Fletikumab (Anti-IL-20)
3-5days
95+%
|
￥3600.00 |
— |
|
|
|
| CLA1335 |
|
1350289-85-8 |
谷瑟庫(kù)單抗
Guselkumab (Anti-IL-23)
3-5days
95+%
|
￥6200.00 |
— |
|
|
|
| CLA1317 |
|
1326244-10-3 |
替曲吉珠單抗
Tildrakizumab (Anti-IL-23a)
3-5days
95+%
|
￥3600.00 |
— |
|
|
|
| CLA1316 |
|
1190264-60-8 |
度匹魯單抗
Dupilumab (anti-IL-4Rα)
3-5days
95+%
|
￥3000.00 |
— |
|
|
|
| CLA1311 |
|
1331830-76-2 |
培拉凱珠單抗
Perakizumab (Anti-CTLA-8 / IL-17a)
3-5days
95+%
|
￥4000.00 |
— |
|
|
|
| CLA1298 |
|
1236278-28-6 |
克拉扎珠單抗
Clazakizumab (Anti-IL-6 / IFNb2)
3-5days
95+%
|
￥4000.00 |
— |
|
|
|
| CLA1288 |
|
1189541-98-7 |
薩瑞魯單
Sarilumab (anti-IL-6Rα)
3-5days
95+%
|
￥2500.00 |
— |
|
|
|
| CLA1285 |
|
1194585-53-9 |
西魯庫(kù)單抗
Sirukumab (Anti-IL-6 / IFNb2)
3-5days
95+%
|
￥3500.00 |
— |
|
|
|
| CLA1281 |
|
1143503-69-8 |
伊卡組單抗
Ixekizumab (Anti-CTLA-8 / IL-17a)
3-5days
95+%
|
￥1800.00 |
— |
|
|
|
| CLA1278 |
|
1174395-19-7 |
布羅達(dá)單抗
Brodalumab (anti-IL17RA)
3-5days
95+%
|
￥2000.00 |
— |
|
|
|
| CLA1264 |
|
909875-08-7 |
依諾凱組單抗
Enokizumab (Anti-IL-9)
3-5days
95+%
|
￥1800.00 |
— |
|
|
|
| CLA1257 |
|
1007223-17-7 |
奧洛組單抗
Olokizumab (Anti-IL-6 / IFNb2)
3-5days
95+%
|
￥2500.00 |
— |
|
|
|
| CLA1249 |
|
1044511-01-4 |
苯拉組單抗
Benralizumab (Anti-IL-5Ra/ CD125)
3-5days
95+%
|
￥9000.00 |
— |
|
|
|
| CLA1243 |
|
953400-68-5 |
來(lái)瑞組單抗
Lebrikizumab (Anti-IL-13)
3-5days
95+%
|
￥4000.00 |
— |
|
|
|
| CLA1242 |
|
1007106-86-6 |
非扎奴單抗
Fezakinumab (Anti-IL-22)
3-5days
95+%
|
￥3500.00 |
— |
|
|
|
| CLA1210 |
|
241473-69-8 |
瑞利珠單抗
Reslizumab
3-5days
95+%
|
￥9000.00 |
— |
|
|
|
| CLA1205 |
|
468715-71-1 |
艾西莫單抗
Elsilimomab (Anti-IL-6 / IFNb2)
3-5days
95+%
|
￥4200.00 |
— |
|
|
|
